<DOC>
	<DOCNO>NCT01656109</DOCNO>
	<brief_summary>There data efficacy , safety pharmacokinetics ATV/r-based HAART HIV-infected Asian child . Therefore , investigator aim evaluate pharmacokinetics , efficacy safety ATV/r-based HAART Thai HIV-infected child .</brief_summary>
	<brief_title>Atazavanir/Ritonavir-based HAART Children</brief_title>
	<detailed_description>Non-nucleoside reverse transcriptase inhibitor ( NNRTI ) -based HAART commonly prescribe first-line HAART HIV-infected child resource-limited setting . Protease inhibitor ( PI ) -based HAART recommend second-line regimen fail NNRTI-based HAART . The commonly use PI Thailand lopinavir/ritonavir ( LPV/r ) . However , metabolic complication lopinavir/ritonaive ( LPV/r ) hyperlipidemia lipodyrtrophy common concern HIV-infected child may contribute development cardiovascular disease long term . There data efficacy , safety pharmacokinetics ATV/r-based HAART HIV-infected adult none child . Furthermore , many study adult child show different ethnicity result different pharmacokinetic response antiretroviral drug . As result , study investigate efficacy , safety pharmacokinetics ATV/r-based HAART HIV-infected Asian child .</detailed_description>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Atazanavir Sulfate</mesh_term>
	<criteria>1 . HIVinfected child 2 . Age 6 18 year old 3 . Body weight â‰¥ 25 kg screen visit 4 . ARV history , child categorize one 2 group 5 . ALT &lt; 200 IU/L screen visit 6 . Total bilirubin &lt; 3 mg/dL screen visit 7 . Can swallow capsule 8 . Written inform consent caregiver assent ( child age 717 year know HIV status ) 1 . Active opportunistic infection 2 . Relevant history current condition , illness might interfere atazanavir/ritonavir absorption , distribution , metabolism excretion . 3 . Use concomitant medication may interfere pharmacokinetics ATV/r ( i.e . efavirenz , indinavir , proton pump inhibitor , antacid , cisapride , clarithromycin , rifampin etc . ) 4 . Pregnancy lactate screen visit 5 . Liver diseases e.g . hepatitis B carrier , chronic hepatitis , cirrhosis 6 . Inability understand nature extent study procedure require .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>pharmacokinetics</keyword>
	<keyword>atazanavir/ritonavir</keyword>
	<keyword>HIV-infected child</keyword>
</DOC>